Safety · 2026-11-10
CHOP poison center reports recent pediatric kratom-related consultations
Source: Children’s Hospital of Philadelphia
Why it matters
The Poison Control Center at Children’s Hospital of Philadelphia describes recent consultations involving critically ill children and adolescents after reported exposure to kratom-related products. The clinical account raises concerns but supplies no case count, exposure denominator or product-specific risk estimate.
The big picture
In a November 10 update, toxicologists Kevin Osterhoudt and Anthony Jaworski describe problems their center encountered during the preceding month. Their discussion covers botanical kratom and several related alkaloids, which should not be treated as interchangeable exposures. This is a local clinical update, separate from the national poison-center analysis it cites.
Key findings
- The center reports consultations involving unresponsive toddlers hospitalized in intensive care after exploratory ingestion of kratom-related drugs. The post provides no number of children or laboratory-confirmed product composition.
- The authors also describe adolescents hospitalized in intensive care with markedly reduced alertness after kratom-product use, as well as adolescents seeking help for withdrawal after stopping chronic use.
- Other consultations concerned neonatal opioid withdrawal associated with kratom use during pregnancy and questions about breastfeeding during maternal use. A breastfeeding consultation alone does not establish an infant injury.
- The authors report that pseudoindoxyl intoxications followed by their center seemed especially severe and prolonged. They provide no comparative case series that would quantify its risk relative to other products.
- Product labels may not reliably identify ingredients or doses, and most hospital laboratories cannot test for kratom or its analogs, the authors caution. These observations cannot establish how often serious outcomes occur among users.
What they say
Osterhoudt and Jaworski advise clinicians to document the precise product, brand and claimed ingredients when possible, and to report suspected exposures to a poison center.
Bottom line
CHOP’s poison center describes recent serious pediatric presentations involving kratom-related products, but the update does not quantify case numbers, establish product composition or measure population-level risk.